世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界の生殖・不妊診断市場レポート、歴史と予測2018-2029年、企業別、主要地域別、タイプ別、用途別内訳データGlobal Reproductive and Fertility Diagnosis Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application QYResearch社の生殖医療と受胎能診断に関する調査レポート「生殖医療と受胎能診断」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の生殖・受胎能診断市... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーQYResearch社の生殖医療と受胎能診断に関する調査レポート「生殖医療と受胎能診断」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の生殖・受胎能診断市場は、2022年の4億2,100万米ドルから2029年には9億9,482万米ドルに達すると予測され、2023年から2029年までのCAGRは13.1%である。予防と診断の需要が業界の主な牽引役である。世界の医薬品市場は2022年に1,475億ドルで、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造部門の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、過去の分析（2018-2022年）と予測計算（2023-2029年）に基づき、読者が世界の生殖・受胎能診断市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分な支援を提供する。 報告書に掲載されている企業、タイプ、用途、地域 企業別 北京Youxun医学研究所 上海許康医療技術 アンノロード・ジーン・テクノロジー（北京） BGIジェノミクス 北京ジャブレフー医学技術 ハイク・ジーン・テクノロジー プレシジョンMDX 上海エピカン・ジェネテック社 杭州ヘイジーンテクノロジー 北京バイオマーカー技術 キャピタルバイオ 上海麗炳生物医学技術 タイプ別セグメント 男性 女性 用途別セグメント 予防 診断 治療 地域別 北米 米国 カナダ ヨーロッパ ドイツ フランス 英国 イタリア ロシア 北欧諸国 アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア ラテンアメリカ メキシコ ブラジル 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 本レポートの各章は、読者が生殖・受胎能診断市場をさらに理解するための詳細情報を提供しています： 第1章：歴史と予測期間（2018-2023年、2024-2029年）の世界と地域の市場規模とCAGR。 第2章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける各タイプの製品タイプと収益分析。 第3章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途と各用途の収益分析。 第4章：企業競争状況、製品名企業の競争状況、収益、市場シェアとランキング、最新の開発計画、合併、買収情報などの詳細分析。 第5章：企業概要：企業の基本情報、生殖医療と不妊治療の紹介など。また、各企業の生殖医療と不妊治療の売上高とグロスマージン、最近の動向もこの部分に含まれています。 第6章から第10章：北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカの国別レベル分析（収益別）。 第11章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク。 第12章：包括的調査に基づく生殖・受胎能診断市場に関するQYResearch社の結論 第13章：QYResearchが採用した方法論とデータソース。 目次1 Market Overview of Reproductive and Fertility Diagnosis1.1 Reproductive and Fertility Diagnosis Market Overview 1.1.1 Reproductive and Fertility Diagnosis Product Scope 1.1.2 Reproductive and Fertility Diagnosis Market Status and Outlook 1.2 Global Reproductive and Fertility Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029 1.3 Global Reproductive and Fertility Diagnosis Market Size by Region (2018-2029) 1.4 Global Reproductive and Fertility Diagnosis Historic Market Size by Region (2018-2023) 1.5 Global Reproductive and Fertility Diagnosis Market Size Forecast by Region (2024-2029) 1.6 Key Regions, Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.1 North America Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.2 Europe Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.3 Asia-Pacific Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.4 Latin America Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.5 Middle East & Africa Reproductive and Fertility Diagnosis Market Size (2018-2029) 2 Reproductive and Fertility Diagnosis Market by Type 2.1 Introduction 2.1.1 Male 2.1.2 Female 2.2 Global Reproductive and Fertility Diagnosis Market Size by Type: 2018 VS 2022 VS 2029 2.2.1 Global Reproductive and Fertility Diagnosis Historic Market Size by Type (2018-2023) 2.2.2 Global Reproductive and Fertility Diagnosis Forecasted Market Size by Type (2024-2029) 2.3 Key Regions Market Size by Type 2.3.1 North America Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.2 Europe Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.3 Asia-Pacific Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.4 Latin America Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.5 Middle East and Africa Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 3 Reproductive and Fertility Diagnosis Market Overview by Application 3.1 Introduction 3.1.1 Prevention 3.1.2 Diagnosis 3.1.3 Treat 3.2 Global Reproductive and Fertility Diagnosis Market Size by Application: 2018 VS 2022 VS 2029 3.2.1 Global Reproductive and Fertility Diagnosis Historic Market Size by Application (2018-2023) 3.2.2 Global Reproductive and Fertility Diagnosis Forecasted Market Size by Application (2024-2029) 3.3 Key Regions Market Size by Application 3.3.1 North America Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.2 Europe Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.3 Asia-Pacific Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.4 Latin America Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.5 Middle East and Africa Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 4 Reproductive and Fertility Diagnosis Competition Analysis by Players 4.1 Global Reproductive and Fertility Diagnosis Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Reproductive and Fertility Diagnosis as of 2022) 4.3 Date of Key Players Enter into Reproductive and Fertility Diagnosis Market 4.4 Global Top Players Reproductive and Fertility Diagnosis Headquarters and Area Served 4.5 Key Players Reproductive and Fertility Diagnosis Product Solution and Service 4.6 Competitive Status 4.6.1 Reproductive and Fertility Diagnosis Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles 5.1 Beijing Youxun Medical Laboratory 5.1.1 Beijing Youxun Medical Laboratory Profile 5.1.2 Beijing Youxun Medical Laboratory Main Business 5.1.3 Beijing Youxun Medical Laboratory Reproductive and Fertility Diagnosis Products, Services and Solutions 5.1.4 Beijing Youxun Medical Laboratory Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.1.5 Beijing Youxun Medical Laboratory Recent Developments 5.2 Shanghai Xukang Medical Technology 5.2.1 Shanghai Xukang Medical Technology Profile 5.2.2 Shanghai Xukang Medical Technology Main Business 5.2.3 Shanghai Xukang Medical Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.2.4 Shanghai Xukang Medical Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.2.5 Shanghai Xukang Medical Technology Recent Developments 5.3 Annoroad Gene Technology (Beijing) 5.3.1 Annoroad Gene Technology (Beijing) Profile 5.3.2 Annoroad Gene Technology (Beijing) Main Business 5.3.3 Annoroad Gene Technology (Beijing) Reproductive and Fertility Diagnosis Products, Services and Solutions 5.3.4 Annoroad Gene Technology (Beijing) Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.3.5 BGI Genomics Recent Developments 5.4 BGI Genomics 5.4.1 BGI Genomics Profile 5.4.2 BGI Genomics Main Business 5.4.3 BGI Genomics Reproductive and Fertility Diagnosis Products, Services and Solutions 5.4.4 BGI Genomics Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.4.5 BGI Genomics Recent Developments 5.5 Peking Jabrehoo Med Tech 5.5.1 Peking Jabrehoo Med Tech Profile 5.5.2 Peking Jabrehoo Med Tech Main Business 5.5.3 Peking Jabrehoo Med Tech Reproductive and Fertility Diagnosis Products, Services and Solutions 5.5.4 Peking Jabrehoo Med Tech Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.5.5 Peking Jabrehoo Med Tech Recent Developments 5.6 Hyk Gene Technology 5.6.1 Hyk Gene Technology Profile 5.6.2 Hyk Gene Technology Main Business 5.6.3 Hyk Gene Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.6.4 Hyk Gene Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.6.5 Hyk Gene Technology Recent Developments 5.7 PrecisionMDX 5.7.1 PrecisionMDX Profile 5.7.2 PrecisionMDX Main Business 5.7.3 PrecisionMDX Reproductive and Fertility Diagnosis Products, Services and Solutions 5.7.4 PrecisionMDX Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.7.5 PrecisionMDX Recent Developments 5.8 Shanghai Epican Genetech Company 5.8.1 Shanghai Epican Genetech Company Profile 5.8.2 Shanghai Epican Genetech Company Main Business 5.8.3 Shanghai Epican Genetech Company Reproductive and Fertility Diagnosis Products, Services and Solutions 5.8.4 Shanghai Epican Genetech Company Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.8.5 Shanghai Epican Genetech Company Recent Developments 5.9 Hangzhou Heyi Gene Technology 5.9.1 Hangzhou Heyi Gene Technology Profile 5.9.2 Hangzhou Heyi Gene Technology Main Business 5.9.3 Hangzhou Heyi Gene Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.9.4 Hangzhou Heyi Gene Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.9.5 Hangzhou Heyi Gene Technology Recent Developments 5.10 Beijing Biomarker Techologies 5.10.1 Beijing Biomarker Techologies Profile 5.10.2 Beijing Biomarker Techologies Main Business 5.10.3 Beijing Biomarker Techologies Reproductive and Fertility Diagnosis Products, Services and Solutions 5.10.4 Beijing Biomarker Techologies Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.10.5 Beijing Biomarker Techologies Recent Developments 5.11 CapitalBio 5.11.1 CapitalBio Profile 5.11.2 CapitalBio Main Business 5.11.3 CapitalBio Reproductive and Fertility Diagnosis Products, Services and Solutions 5.11.4 CapitalBio Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.11.5 CapitalBio Recent Developments 5.12 Shanghai Liebing Biomedical Technology 5.12.1 Shanghai Liebing Biomedical Technology Profile 5.12.2 Shanghai Liebing Biomedical Technology Main Business 5.12.3 Shanghai Liebing Biomedical Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.12.4 Shanghai Liebing Biomedical Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.12.5 Shanghai Liebing Biomedical Technology Recent Developments 6 North America 6.1 North America Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic Countries 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Reproductive and Fertility Diagnosis Market Size by Region (2018-2029) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Reproductive and Fertility Diagnosis Market Dynamics 11.1 Reproductive and Fertility Diagnosis Industry Trends 11.2 Reproductive and Fertility Diagnosis Market Drivers 11.3 Reproductive and Fertility Diagnosis Market Challenges 11.4 Reproductive and Fertility Diagnosis Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List
SummaryReproductive and Fertility Diagnosis report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Reproductive and Fertility Diagnosis market is projected to reach US$ 9948.2 million in 2029, increasing from US$ 4214 million in 2022, with the CAGR of 13.1% during the period of 2023 to 2029. Demand from Prevention and Diagnosis are the major drivers for the industry. Table of Contents1 Market Overview of Reproductive and Fertility Diagnosis1.1 Reproductive and Fertility Diagnosis Market Overview 1.1.1 Reproductive and Fertility Diagnosis Product Scope 1.1.2 Reproductive and Fertility Diagnosis Market Status and Outlook 1.2 Global Reproductive and Fertility Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029 1.3 Global Reproductive and Fertility Diagnosis Market Size by Region (2018-2029) 1.4 Global Reproductive and Fertility Diagnosis Historic Market Size by Region (2018-2023) 1.5 Global Reproductive and Fertility Diagnosis Market Size Forecast by Region (2024-2029) 1.6 Key Regions, Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.1 North America Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.2 Europe Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.3 Asia-Pacific Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.4 Latin America Reproductive and Fertility Diagnosis Market Size (2018-2029) 1.6.5 Middle East & Africa Reproductive and Fertility Diagnosis Market Size (2018-2029) 2 Reproductive and Fertility Diagnosis Market by Type 2.1 Introduction 2.1.1 Male 2.1.2 Female 2.2 Global Reproductive and Fertility Diagnosis Market Size by Type: 2018 VS 2022 VS 2029 2.2.1 Global Reproductive and Fertility Diagnosis Historic Market Size by Type (2018-2023) 2.2.2 Global Reproductive and Fertility Diagnosis Forecasted Market Size by Type (2024-2029) 2.3 Key Regions Market Size by Type 2.3.1 North America Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.2 Europe Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.3 Asia-Pacific Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.4 Latin America Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 2.3.5 Middle East and Africa Reproductive and Fertility Diagnosis Revenue Breakdown by Type (2018-2029) 3 Reproductive and Fertility Diagnosis Market Overview by Application 3.1 Introduction 3.1.1 Prevention 3.1.2 Diagnosis 3.1.3 Treat 3.2 Global Reproductive and Fertility Diagnosis Market Size by Application: 2018 VS 2022 VS 2029 3.2.1 Global Reproductive and Fertility Diagnosis Historic Market Size by Application (2018-2023) 3.2.2 Global Reproductive and Fertility Diagnosis Forecasted Market Size by Application (2024-2029) 3.3 Key Regions Market Size by Application 3.3.1 North America Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.2 Europe Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.3 Asia-Pacific Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.4 Latin America Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 3.3.5 Middle East and Africa Reproductive and Fertility Diagnosis Revenue Breakdown by Application (2018-2029) 4 Reproductive and Fertility Diagnosis Competition Analysis by Players 4.1 Global Reproductive and Fertility Diagnosis Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Reproductive and Fertility Diagnosis as of 2022) 4.3 Date of Key Players Enter into Reproductive and Fertility Diagnosis Market 4.4 Global Top Players Reproductive and Fertility Diagnosis Headquarters and Area Served 4.5 Key Players Reproductive and Fertility Diagnosis Product Solution and Service 4.6 Competitive Status 4.6.1 Reproductive and Fertility Diagnosis Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles 5.1 Beijing Youxun Medical Laboratory 5.1.1 Beijing Youxun Medical Laboratory Profile 5.1.2 Beijing Youxun Medical Laboratory Main Business 5.1.3 Beijing Youxun Medical Laboratory Reproductive and Fertility Diagnosis Products, Services and Solutions 5.1.4 Beijing Youxun Medical Laboratory Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.1.5 Beijing Youxun Medical Laboratory Recent Developments 5.2 Shanghai Xukang Medical Technology 5.2.1 Shanghai Xukang Medical Technology Profile 5.2.2 Shanghai Xukang Medical Technology Main Business 5.2.3 Shanghai Xukang Medical Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.2.4 Shanghai Xukang Medical Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.2.5 Shanghai Xukang Medical Technology Recent Developments 5.3 Annoroad Gene Technology (Beijing) 5.3.1 Annoroad Gene Technology (Beijing) Profile 5.3.2 Annoroad Gene Technology (Beijing) Main Business 5.3.3 Annoroad Gene Technology (Beijing) Reproductive and Fertility Diagnosis Products, Services and Solutions 5.3.4 Annoroad Gene Technology (Beijing) Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.3.5 BGI Genomics Recent Developments 5.4 BGI Genomics 5.4.1 BGI Genomics Profile 5.4.2 BGI Genomics Main Business 5.4.3 BGI Genomics Reproductive and Fertility Diagnosis Products, Services and Solutions 5.4.4 BGI Genomics Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.4.5 BGI Genomics Recent Developments 5.5 Peking Jabrehoo Med Tech 5.5.1 Peking Jabrehoo Med Tech Profile 5.5.2 Peking Jabrehoo Med Tech Main Business 5.5.3 Peking Jabrehoo Med Tech Reproductive and Fertility Diagnosis Products, Services and Solutions 5.5.4 Peking Jabrehoo Med Tech Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.5.5 Peking Jabrehoo Med Tech Recent Developments 5.6 Hyk Gene Technology 5.6.1 Hyk Gene Technology Profile 5.6.2 Hyk Gene Technology Main Business 5.6.3 Hyk Gene Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.6.4 Hyk Gene Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.6.5 Hyk Gene Technology Recent Developments 5.7 PrecisionMDX 5.7.1 PrecisionMDX Profile 5.7.2 PrecisionMDX Main Business 5.7.3 PrecisionMDX Reproductive and Fertility Diagnosis Products, Services and Solutions 5.7.4 PrecisionMDX Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.7.5 PrecisionMDX Recent Developments 5.8 Shanghai Epican Genetech Company 5.8.1 Shanghai Epican Genetech Company Profile 5.8.2 Shanghai Epican Genetech Company Main Business 5.8.3 Shanghai Epican Genetech Company Reproductive and Fertility Diagnosis Products, Services and Solutions 5.8.4 Shanghai Epican Genetech Company Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.8.5 Shanghai Epican Genetech Company Recent Developments 5.9 Hangzhou Heyi Gene Technology 5.9.1 Hangzhou Heyi Gene Technology Profile 5.9.2 Hangzhou Heyi Gene Technology Main Business 5.9.3 Hangzhou Heyi Gene Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.9.4 Hangzhou Heyi Gene Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.9.5 Hangzhou Heyi Gene Technology Recent Developments 5.10 Beijing Biomarker Techologies 5.10.1 Beijing Biomarker Techologies Profile 5.10.2 Beijing Biomarker Techologies Main Business 5.10.3 Beijing Biomarker Techologies Reproductive and Fertility Diagnosis Products, Services and Solutions 5.10.4 Beijing Biomarker Techologies Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.10.5 Beijing Biomarker Techologies Recent Developments 5.11 CapitalBio 5.11.1 CapitalBio Profile 5.11.2 CapitalBio Main Business 5.11.3 CapitalBio Reproductive and Fertility Diagnosis Products, Services and Solutions 5.11.4 CapitalBio Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.11.5 CapitalBio Recent Developments 5.12 Shanghai Liebing Biomedical Technology 5.12.1 Shanghai Liebing Biomedical Technology Profile 5.12.2 Shanghai Liebing Biomedical Technology Main Business 5.12.3 Shanghai Liebing Biomedical Technology Reproductive and Fertility Diagnosis Products, Services and Solutions 5.12.4 Shanghai Liebing Biomedical Technology Reproductive and Fertility Diagnosis Revenue (US$ Million) & (2018-2023) 5.12.5 Shanghai Liebing Biomedical Technology Recent Developments 6 North America 6.1 North America Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic Countries 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Reproductive and Fertility Diagnosis Market Size by Region (2018-2029) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Reproductive and Fertility Diagnosis Market Size by Country (2018-2029) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Reproductive and Fertility Diagnosis Market Dynamics 11.1 Reproductive and Fertility Diagnosis Industry Trends 11.2 Reproductive and Fertility Diagnosis Market Drivers 11.3 Reproductive and Fertility Diagnosis Market Challenges 11.4 Reproductive and Fertility Diagnosis Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（breakdown data）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/18 10:27 154.74 円 162.88 円 199.42 円 |
